Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis

被引：16

作者：

Ordaya, Eloy E. ^{[1
]}

Beam, Elena ^{[1
]}

Yao, Joseph D. ^{[2
]}

Razonable, Raymund R. ^{[1
]}

Vergidis, Paschalis ^{[1
]}

机构：

[1] Mayo Clin, Div Infect Dis, Dept Med, 200 First St SW, Rochester, MN 55905 USA

[2] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 07期

关键词：

COVID-19; immunocompromised hosts; monoclonal antibodies; transplant infectious diseases;

D O I：

10.1093/ofid/ofac283

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Tixagevimab-cilgavimab is authorized for preexposure prophylaxis against coronavirus disease 2019 (COVID-19) in immunocompromised hosts. Herein, we report the clinical characteristics of 8 patients who developed COVID-19 soon after receiving tixagevimab-cilgavimab. This study emphasizes the need to maintain additional measures to prevent COVID-19 during periods of high severe acute respiratory syndrome coronavirus 2 transmission.

引用

页数：5

共 24 条

[21]

US Food and Drug Administration, Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

[22] An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies [J].

VanBlargan, Laura A. ;

Errico, John M. ;

Halfmann, Peter J. ;

Zost, Seth J. ;

Crowe, James E., Jr. ;

Purcell, Lisa A. ;

Kawaoka, Yoshihiro ;

Corti, Davide ;

Fremont, Daved H. ;

Diamond, Michael S. .

NATURE MEDICINE, 2022, 28 (03) :490-+

[23] Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies [J].

Wang, Xun ;

Zhao, Xiaoyu ;

Song, Jieyu ;

Wu, Jing ;

Zhu, Yuqi ;

Li, Minghui ;

Cui, Yuchen ;

Chen, Yanjia ;

Yang, Lulu ;

Liu, Jun ;

Zhu, Huanzhang ;

Jiang, Shibo ;

Wang, Pengfei .

EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :477-481

[24] Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy [J].

Yetmar, Zachary A. ;

Bhaimia, Eric ;

Bierle, Dennis M. ;

Ganesh, Ravindra ;

Razonable, Raymund R. .

TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (02)

← 1 2 3 →